
The fund is an actively managed exchange-traded fund (“ETF”) that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of the fund’s net assets (plus the amount of any borrowings for investment purposes) in U.S. listed common stock.
Is SMRI's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.

Bushido Capital US Equity ETF (NASDAQ: SMRI - Get Free Report) saw a large drop in short interest during the month of February. As of February 27th, there was short interest totaling 5,982 shares, a drop of 78.0% from the February 12th total of 27,180 shares. Based on an average daily volume of 8,523 shares, the

Bushido Capital US Equity ETF (NASDAQ: SMRI - Get Free Report) shares saw unusually-strong trading volume on Friday. Approximately 30,342 shares traded hands during trading, an increase of 717% from the previous session's volume of 3,712 shares.The stock last traded at $37.16 and had previously closed at $37.02. Bushido Capital US Equity ETF Trading Up

The Bushido Capital US Equity ETF is currently too expensive and not well-positioned for a potential economic downturn, especially given its low allocation to resilient sectors like consumer staples and utilities. SMRI is heavily weighted towards healthcare and consumer cyclical sectors, which may benefit from falling interest rates, but it's too early to rotate into value stocks. The Fed's interest rate cuts are uncertain and may not lead to rapid declines, making it premature to invest in this ETF for short-term gains.

The past week saw a spike in ETF launches, with 19 new funds debuting.